Inventor
GUIMBERTEAU FLORENCE
FR24 patents
⚠️ This page may combine multiple inventors who share the name “GUIMBERTEAU FLORENCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEVA SANTE ANIMALE
11 patentsUS11903947B2Feb 20, 2024
Triazine formulations with a second active ingredient and surfactant(s)
CEVA SANTE ANIMALE1 citations70
US11331321B2May 17, 2022
Triazine formulations with a second active ingredient and surfactant(s)
CEVA SANTE ANIMALE3 citations70
US11911391B2Feb 27, 2024
Triazine formulations with a second active ingredient and surfactant(s)
CEVA SANTE ANIMALE0 citations59
US11903946B2Feb 20, 2024
Triazine formulations with a second active ingredient and surfactant(s)
CEVA SANTE ANIMALE0 citations59
US12257226B2Mar 25, 2025
Veterinary compositions and the uses thereof for controlling iron deficiencies in non-human mammals
CEVA SANTE ANIMALE0 citations57
US11318156B2May 3, 2022
Solid injectable veterinary implants comprising monocyclic lactone
CEVA SANTE ANIMALE0 citations57
US11090270B2Aug 17, 2021
Palatable oral veterinary compositions
CEVA SANTE ANIMALE0 citations57
US11020350B2Jun 1, 2021
Palatable oral veterinary compositions
CEVA SANTE ANIMALE0 citations57
USD1065719SMar 4, 2025
Nose ring for animals
CEVA SANTE ANIMALE0 citations56
US11872208B2Jan 16, 2024
Composition for treating parasites infestations
CEVA SANTE ANIMALE0 citations54
US12342792B2Jul 1, 2025
Nose ring for ruminants
CEVA SANTE ANIMALE0 citations45
GUIMBERTEAU FLORENCE
6 patentsUS8652529B2Feb 18, 2014
Anti-misuse microparticulate oral pharmaceutical form
GUIMBERTEAU FLORENCE78 citations95
US8445023B2May 21, 2013
Anti-misuse microparticulate oral pharmaceutical form
GUIMBERTEAU FLORENCE94 citations95
US8652523B2Feb 18, 2014
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
GUIMBERTEAU FLORENCE42 citations93
US9023400B2May 5, 2015
Prolonged-release multimicroparticulate oral pharmaceutical form
GUIMBERTEAU FLORENCE54 citations92
US8821935B2Sep 2, 2014
Microcapsules with modified release of active principles with low solubility for oral delivery
GUIMBERTEAU FLORENCE42 citations90
US8895063B2Nov 25, 2014
Oral dosage form comprising an antimisuse system
GUIMBERTEAU FLORENCE12 citations80
FLAMEL TECH SA
2 patentsUS7906145B2Mar 15, 2011
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FLAMEL TECH SA101 citations97
US7910133B2Mar 22, 2011
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
FLAMEL TECH SA8 citations84
FLAMEL IRELAND LTD
2 patentsUSRE47084EOct 16, 2018
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
FLAMEL IRELAND LTD36 citations94
US9814684B2Nov 14, 2017
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FLAMEL IRELAND LTD36 citations92
CASTAN CATHERINE
2 patentsUS8734850B2May 27, 2014
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
CASTAN CATHERINE39 citations93
US10004693B2Jun 26, 2018
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
CASTAN CATHERINE36 citations92